Scaling up for bigger impact in climate, circularity and human rights
BWI
4 min read
47

Scaling up for bigger impact in climate, circularity and human rights

November 14, 2024
0

Reading Time: 3 minutes Herzogenaurach, Germany:   Sports company PUMA has announced its new Vision 2030 sustainability goals, which expand on the strong progress the brand has made.   This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241114901121/en/   PUMA Headquarters at Herzogenaurach (Photo:

Continue Reading
NIIT Learning Systems Limited (NIIT MTS) Ranked Among Training Industry’s Top 20 IT and Technical Training Companies, 2024
BWI
4 min read
37

NIIT Learning Systems Limited (NIIT MTS) Ranked Among Training Industry’s Top 20 IT and Technical Training Companies, 2024

November 14, 2024
0

Reading Time: 3 minutes   Atlanta, GA, United States:  NIIT Learning Systems Limited [NIIT Managed Training Services (NIIT MTS)] (Ticker Symbol: NIITMTS), a global leader in managed learning services, announced that it has been named to the 2024 Top 20 Companies in IT and Technical Training by Training

Continue Reading
CSP
1 min read
11

Aonic AB (publ) publishes interim report for Q3 2024

November 14, 2024
0

Reading Time: < 1 minute Press releaseTHU, November 14, 2024, 09.00 CEST Aonic AB (publ) has today published its Q3 2024 report on the company’s website https://aonic.co/. The report is available on the company’s website as a PDF. For more information:Paul Schempp, CEO +46 76 344

Continue Reading
Merck Foundation Marking “World Diabetes Day” by Providing out of 2080 Scholarships, 830 Scholarships for Diabetes and Hypertension in 52 Countries
BWI
7 min read
40

Merck Foundation Marking “World Diabetes Day” by Providing out of 2080 Scholarships, 830 Scholarships for Diabetes and Hypertension in 52 Countries

November 14, 2024
0

Reading Time: 4 minutes Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World Diabetes Day 2024’ together with Africa’s First Ladies, Ministries of Health, Medical Societies and Academia, through their “Nationwide Diabetes & Hypertension Blue Points Program”. Senator, Dr. Rasha Kelej, CEO of Merck Foundation emphasized, “At Merck Foundation, we

Continue Reading
CSP
5 min read
16

A significant step forward for the quantum secure network in Finland: novel encryption technology tested in a commercial operator’s network

November 14, 2024
0

Reading Time: 3 minutes Press release, 14 November 2024 This week Telia successfully tested the ultra-secure quantum encryption technology in its network in Helsinki as the first commercial operator in Finland. The demo is a significant step in a national project which aims to build a

Continue Reading
CSP
2 min read
9

US-listed company intends to make an offer to take over a minimum of 51% of the shares in DecideAct A/S and has signed LOI

November 14, 2024
0

Reading Time: 2 minutes DecideAct A/S [ACT] NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN DecideAct A/S (the Company) has signed a letter of intent (LOI) with the purpose to receive a binding offer from a US-listed company. The potential acquirer specializes in investing in SaaS companies and wants to

Continue Reading
Tecnotree Selected to Provide Multi-Tenant MVNE Platform and Moments Marketplace to Power Tier 1 MVNE in EMEA
BWI
3 min read
31

Tecnotree Selected to Provide Multi-Tenant MVNE Platform and Moments Marketplace to Power Tier 1 MVNE in EMEA

November 14, 2024
0

Reading Time: 2 minutes Espoo, Finland:   Tecnotree, a global digital Business Support Systems (BSS) provider and a leader in digital transformation solutions, has announced its latest collaboration with a leading MVNE in EMEA. This partnership will harness the multi-tenant capabilities of Tecnotree’s state-of-the-art MVNE platform

Continue Reading
PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen
BWI
4 min read
34

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen

November 14, 2024
0

Reading Time: 3 minutes MUMBAI, India & HYDERABAD, India:  PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part

Continue Reading
CSP
22 min read
24

Africa Oil Announces Third Quarter 2024 Results

November 13, 2024
0

Reading Time: 16 minutes VANCOUVER, BC, Nov. 13, 2024 /CNW/ – (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, “AOC” or the “Company”) is pleased to announce its financial and operating results for the three and nine months ended September 30, 2024. Highlights Satisfied the

Continue Reading
MilDef completes a directed share issue of approximately 5.4 million shares, raising proceeds of SEK 500 million
CSP
16 min read
14

MilDef completes a directed share issue of approximately 5.4 million shares, raising proceeds of SEK 500 million

November 13, 2024
0

Reading Time: 11 minutes MilDef Group AB (publ) (“MilDef” or the “Company”) has successfully carried out a directed share issue of 5,434,782 shares at a subscription price of SEK 92 per share (the “Directed Share Issue”). As a result of the strong demand from both

Continue Reading